# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2131-2140 of 2220 results.
Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma
Status: Completed
Last Changed: Apr 07, 2014
First Received: Jul 30, 2008
Disease(s): Lymphoma, Hodgkin Disease, Lymphoma, Non-Hodgkin
Intervention(s): PCI-24781
Locations: University of California, San Francisco, San Francisco, California, United States
Northwestern University Medical School, Chicago, Illinois, United States
Horizon Oncology Center, Lafayette, Indiana, United States
University of Massachusetts Medical School, Worcester, Massachusetts, United States
Washington University School of Medicine, St. Louis, Missouri, United States
... and 4 other locations.
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
Status: Recruiting
Last Changed: May 29, 2020
First Received: Jun 16, 2017
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell
Intervention(s): Ibrutinib 420 mg, Ibrutinib 560 mg
Locations: Vedanta Institute of Medical Science, Ahmedabad, India
Avron Hospitals Pvt. Ltd, Ahmedabad, India
Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
Basavatarakam Indo-American Hospital, Hyderabad, India
Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur, India
... and 9 other locations.
Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status: Completed
Last Changed: Apr 19, 2016
First Received: Dec 07, 2012
Disease(s): Leukemia Lymphocytic Chronic B-Cell
Intervention(s): CC-292, Rituximab
Locations: Clearview Cancer Institute, Huntsville, Alabama, United States
Horizon Oncology Research, Inc, Lafayette, Indiana, United States
Hackensack UMC, Hackensack, New Jersey, United States
The West Clinic, Memphis, Tennessee, United States
Universitätsklinik Ulm, Ulm, Bayern, Germany
... and 4 other locations.
Donor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Status: Withdrawn
Last Changed: Mar 05, 2014
First Received: Aug 27, 2007
Disease(s): Lymphoma
Intervention(s): anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells
Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
Status: Terminated
Last Changed: Mar 19, 2018
First Received: Jul 02, 2015
Disease(s): DLBCL, MCL, Recurrent Disease
Intervention(s): 90Y-DOTATOC
Locations: Nuclear Medicin Division, IRST IRCCS, Meldola, FC, Italy
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Sep 14, 2020
First Received: Dec 24, 2019
Disease(s): Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): JNJ-64264681
Locations: Icahn School of Medicine at Mount Sinai, New York, New York, United States
Arensia Exploratory Medicine, Tbilisi, Georgia
Arensia Exploratory Medicine, Chisinau, Moldova, Republic of
Pratia MCM Krakow, Krakow, Poland
Queen Mary University of London, Charterhouse Square, United Kingdom
... and 2 other locations.
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Status: Completed
Last Changed: Jan 30, 2014
First Received: Jan 10, 2011
Disease(s): Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
Intervention(s): imetelstat sodium, laboratory biomarker analysis, pharmacological study
Locations: UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
Children's Hospital of Orange County, Orange, California, United States
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Children's National Medical Center, Washington, District of Columbia, United States
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States
... and 19 other locations.
An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin's Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL)
Status: Active, not recruiting
Last Changed: Sep 25, 2020
First Received: Sep 20, 2017
Disease(s): Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): MabThera
Locations: Soon Chun Hyang University Hospital Bucheon, Bucheon-si,, Korea, Republic of
Inje University Busan Paik Hospital, Busan, Korea, Republic of
Pusan National University Hospital, Busan, Korea, Republic of
Keimyung University Dongsan Medical Center, Daegu, Korea, Republic of
Yeungnam University Medical Center, Daegu, Korea, Republic of
... and 21 other locations.
A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies
Status: Recruiting
Last Changed: Sep 25, 2020
First Received: Aug 06, 2020
Disease(s): T Cell Lymphoma
Intervention(s): CTX130
Locations: Research Site 2, Duarte, California, United States
Research Site 1, Houston, Texas, United States
Research Site 3, Sydney, New South Wales, Australia
Ublituximab + Ibrutinib in Select B-cell Malignancies
Status: Completed
Last Changed: Oct 02, 2019
First Received: Dec 17, 2013
Disease(s): Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma
Intervention(s): Ublituximab, Ibrutinib
Locations: TG Therapeutics Investigational Trial Site, Huntsville, Alabama, United States
TG Therapeutics Investigational Trial Site, Tucson, Arizona, United States
TG Therapeutics Investigational Trial Site, Santa Barbara, California, United States
TG Therapeutics Investigational Trial Site, Boulder, Colorado, United States
TG Therapeutics Investigational Trial Site, Niles, Illinois, United States
... and 14 other locations.